Comparative study between non-severe and severe Covid-19 infections in the levels of albumin, creatinine, and lactate dehydrogenase

Abstract

This research aimed to compare albumin, creatinine, and lactate dehydrogenase levels in patients with non-severe and severe covid-19 infections. This investigation was conducted at Babylon provincial hospitals and private laboratories labs from October 2020 to December 2021. The research included 30 patients with covid-19 infection, divided into two groups. Each group contains 15 patients depending on infection severity. The serum samples were separated and stored at −20°C until the lactate dehydrogenase, creatinine, and albumin biological tests were performed. The outcomes revealed a substantial decrease (P≤0.05) in albumin levels in severe Covid-19 patients (34.976±3.17) compared to non-severe Covid-19 patients (40±14.765). Also, a considerable increase was observed (P≤0.05) in creatinine levels in severe Covid-19 patients (1.16±0.45) compared to non-severe Covid-19 patients (0.82±0.53). Finally, crucial elevation (P≤0.05) in lactate dehydrogenase level of severe Covid-19 patients (913.27±213.16) compared to the group of non-severe Covid-19 patients (1437.27±251.27). Lactate dehydrogenase, creatinine, and albumin are employed as medical markers in severe covid-19 infection.